Omnicell Q3 Earnings Call Highlights

Omnicell NASDAQ: OMCL reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan XT automated dispensing hardware and remains on track for first-half 2027 general availability of its OmniSphere cloud platform.

MarketBeat • 4 hours ago

Omnicell, Inc. (OMCL) Q3 2026 Earnings Call Transcript

Omnicell, Inc. ( OMCL ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants David Unger - Vice President of Investor Relations Randall Lipps - Founder, Executive Chairman & CEO Nnamdi Njoku - President & COO Baird Radford Conference Call Participants Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Jessica Tassan - Piper Sandler & Co., Research Division Allen Lutz - BofA Securities, Research Division David Larsen - BTIG, LLC, Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Gene Mannheimer William Sutherland - StoneX Financial, Inc., Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to the Omnicell Third Quarter 2026 Financial Results Call.

Seeking Alpha • 2 hours ago

Omnicell Announces Third Quarter 2026 Financial Results

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Third Quarter 2026 Financial Results.

Business Wire • 14 hours ago

Omnicell (OMCL) Q3 Earnings and Revenues Top Estimates

Omnicell (OMCL) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.51 per share a year ago.

Zacks Investment Research • 12 hours ago

Here's What Key Metrics Tell Us About Omnicell (OMCL) Q3 Earnings

While the top- and bottom-line numbers for Omnicell (OMCL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • 10 hours ago

Is This the Right Time to Retain Omnicell Stock in Your Portfolio?

OMCL raises its 2026 earnings outlook on cost discipline and efficiency, but rising memory costs and delayed Titan XT adoption pose challenges.

Zacks Investment Research • Oct 13, 2026

Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026.

Business Wire • Oct 8, 2026

Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Oct 2, 2026

Here's Why Omnicell (OMCL) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Sep 16, 2026

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes. BOSTON, Sept.

PRNewsWire • Sep 3, 2026